Daniel Molina‐Morant

Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II superiority clinical trial

Daniel Molina‐Morant, Marisa Fernández, Pau Bosch‐Nicolau et al. · Trials · 2020 · 61 citations · Full text

Imported endemic mycoses in Spain: Evolution of hospitalized cases, clinical characteristics and correlation with migratory movements, 1997-2014

Daniel Molina‐Morant, Adrián Sánchez‐Montalvá, Fernando Salvador et al. · PLoS neglected tropical diseases · 2018 · 35 citations · Full text

Migratory Movements, Infectious Disease Epidemiology, Diagnostic Mycology +13

Usefulness of FDG PET/CT in the management of tuberculosis

Adrián Sánchez‐Montalvá, Marta Barios, Fernando Salvador et al. · PLoS ONE · 2019 · 34 citations · Full text

Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine

Robert Güerri‐Fernández, Daniel Molina‐Morant, Judit Villar-García et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2017 · 28 citations

<i>Strongyloides stercoralis</i> infection increases the likelihood to detect <i>Trypanosoma cruzi </i><scp>DNA</scp> in peripheral blood in Chagas disease patients

Fernando Salvador, Elena Sulleiro, María Pirón et al. · Tropical Medicine & International Health · 2017 · 23 citations · Full text